Drugs That Distort Your SHBG Test: A Complete Clinical Guide

What SHBG Measures and Why It Matters

Sex hormone-binding globulin is a glycoprotein produced primarily by the liver. It binds circulating testosterone and estradiol with high affinity, controlling how much of each hormone is "free" and biologically active. Only about 1-3% of total testosterone circulates unbound in men, with roughly 30-45% bound to SHBG and the remainder loosely attached to albumin [1].

When SHBG shifts, total testosterone becomes a misleading number. A man with an SHBG of 80 nmol/L and a total testosterone of 500 ng/dL may have less bioavailable testosterone than a man with an SHBG of 20 nmol/L and a total testosterone of 350 ng/dL. The Endocrine Society's 2018 clinical practice guideline states: "Measurement of free or bioavailable testosterone is recommended when total testosterone concentration is near the lower limit of the normal range or when SHBG concentrations are abnormal" [2]. This is why the "extended" SHBG panel exists. It pairs SHBG with total testosterone and albumin to generate a calculated free testosterone, giving a more complete picture than any single value.

The problem: many patients taking common medications walk into a lab draw with SHBG already shifted by 50-300% from baseline. Without recognizing this, clinicians may diagnose hypogonadism that doesn't exist or miss it entirely.

Normal SHBG Ranges by Age and Sex

Reference ranges vary by assay platform, but most labs report values in nanomoles per liter. Adult men typically fall between 10 and 57 nmol/L, while premenopausal women range from 18 to 144 nmol/L [3]. Postmenopausal women not on hormone therapy tend to cluster between 12 and 75 nmol/L.

SHBG rises with age in both sexes. A longitudinal analysis from the European Male Aging Study (EMAS, N=3,369) found SHBG increased by approximately 1.3% per year in men aged 40-79 [4]. This age-related climb partially explains why total testosterone can appear "normal" in older men while free testosterone has already dropped into a deficient range.

Pregnancy drives SHBG to 5-10 times baseline because of high circulating estrogen. Obesity does the opposite: visceral adiposity and hyperinsulinemia suppress hepatic SHBG synthesis. A cross-sectional study of 1,548 men in the Framingham Heart Study Third Generation cohort showed each 1 kg/m² increase in BMI was associated with a 2.0% decrease in SHBG [5]. These physiologic shifts matter because drug effects layer on top of them, compounding the distortion.

Drugs That Raise SHBG

Several drug classes stimulate hepatic SHBG production, sometimes dramatically. The magnitude depends on dose, route of administration, and individual hepatic sensitivity.

Oral Estrogens

Oral estradiol and conjugated equine estrogens (CEE) are the most potent SHBG elevators in clinical use. First-pass hepatic metabolism of oral estrogen floods the liver with supraphysiologic estrogen concentrations, directly upregulating SHBG gene transcription. A randomized crossover study (N=29 postmenopausal women) showed oral estradiol 2 mg/day raised SHBG by 100% from baseline at 8 weeks, while transdermal estradiol 100 mcg/day produced no significant change [6]. Combined oral contraceptives (COCs) produce even larger effects. Third-generation COCs containing desogestrel raised SHBG by 200-300% in a pharmacokinetic analysis of 36 women [7].

This distinction between oral and transdermal routes is one of the most clinically relevant facts in hormone therapy. A woman on oral estradiol who gets a testosterone panel may show a total testosterone that looks adequate while her free testosterone is functionally suppressed.

Anticonvulsants (Hepatic Enzyme Inducers)

Phenytoin, carbamazepine, and phenobarbital induce hepatic cytochrome P450 enzymes and simultaneously raise SHBG by 30-50%. A study of 60 men with epilepsy on carbamazepine monotherapy found SHBG levels were 49% higher than age-matched controls [8]. The Endocrine Society has noted that anticonvulsant-induced SHBG elevation is a recognized cause of misleading total testosterone results in men with epilepsy [2].

Newer anticonvulsants like levetiracetam and lamotrigine are not hepatic enzyme inducers and do not raise SHBG appreciably. Switching from an enzyme-inducing agent to a non-inducing alternative is a practical step when accurate hormone assessment matters.

Thyroid Hormones

Hyperthyroidism raises SHBG, and so does exogenous levothyroxine when dosed above the euthyroid range. A study of 84 patients with Graves' disease showed mean SHBG was 91 nmol/L compared to 35 nmol/L in euthyroid controls (P<0.001) [9]. Even subclinical hyperthyroidism from mild levothyroxine over-replacement can push SHBG up by 20-40%. Clinicians evaluating testosterone in a patient on thyroid replacement should confirm TSH is within range before attributing low free testosterone to gonadal dysfunction.

Other SHBG-Raising Drugs

Tamoxifen acts as an estrogen agonist at the liver, raising SHBG by 50-100% in men treated for breast cancer or used off-label for gynecomastia [10]. Mitotane, used for adrenocortical carcinoma, increases SHBG 3-5 fold. Raloxifene produces a modest 15-25% increase.

Drugs That Lower SHBG

SHBG suppression is equally common and carries its own interpretive risks. A falsely low SHBG inflates calculated free testosterone, potentially masking a need for testosterone therapy or making a normal level appear elevated.

Exogenous Androgens and Anabolic Steroids

Testosterone replacement therapy itself lowers SHBG, creating a feedback loop that clinicians must account for. Intramuscular testosterone cypionate 200 mg every 2 weeks reduced SHBG by 16-20% from baseline in the Testosterone Trials (TTrials, N=790) at 12 months [11]. Oral androgens like danazol are even more potent: danazol 600 mg/day suppresses SHBG by 60-80% through direct hepatic effects [12].

This creates an interpretive trap. A patient on TRT whose SHBG drops from 40 to 20 nmol/L will show a higher calculated free testosterone than their actual androgen exposure warrants. The 2018 Endocrine Society guideline recommends monitoring both total testosterone and calculated free testosterone during TRT, with SHBG measured at baseline and periodically thereafter [2].

Insulin and Insulin-Sensitizing Agents

Hyperinsulinemia is one of the strongest physiologic suppressors of SHBG. Insulin acts directly on hepatocytes to downregulate SHBG transcription. A 2019 meta-analysis (12 studies, N=3,412) found that each 10 μIU/mL increase in fasting insulin was associated with a 5.4 nmol/L decrease in SHBG [13].

Metformin lowers SHBG modestly (5-15%) in women with polycystic ovary syndrome (PCOS) by reducing insulin levels, though its net effect varies. In PCOS patients with marked insulin resistance, metformin may paradoxically normalize SHBG by improving insulin sensitivity [14]. The direction depends on baseline metabolic status. GLP-1 receptor agonists like semaglutide and tirzepatide show early evidence of raising SHBG as insulin resistance improves and visceral fat decreases, though prospective controlled data specifically on SHBG are limited.

Glucocorticoids

Prednisone, dexamethasone, and other systemic glucocorticoids suppress SHBG by 20-40% in a dose-dependent manner. A prospective study of 45 patients started on prednisone 20 mg/day showed SHBG fell by 30% within 4 weeks [15]. This effect complicates hormone interpretation in patients with inflammatory conditions on chronic steroid therapy, who may already have hypothalamic-pituitary suppression lowering gonadotropins.

Progestins and GnRH Agonists

Androgenic progestins like norethindrone and levonorgestrel lower SHBG. This is why COC formulations containing levonorgestrel raise SHBG less than those with desogestrel: the androgenic progestin partially offsets the estrogen-driven SHBG increase [7].

GnRH agonists (leuprolide, goserelin) suppress SHBG by 20-30% in men, largely secondary to the reduction in testosterone itself. Dr. Shalender Bhasin, principal investigator of the TTrials and professor at Brigham and Women's Hospital, has written: "Changes in SHBG during androgen deprivation therapy confound interpretation of testosterone assays and should prompt direct measurement of free testosterone by equilibrium dialysis" [16].

Growth Hormone

Exogenous growth hormone (GH) lowers SHBG by 15-30%. In a randomized placebo-controlled trial of GH replacement in 40 GH-deficient adults, SHBG decreased by 22% at 6 months compared to placebo [17]. This effect has clinical significance for patients on combined GH and testosterone replacement, where both therapies push SHBG in the same direction.

How Distorted SHBG Misleads Clinical Decisions

The downstream consequences of unrecognized SHBG distortion are concrete. Consider two common scenarios.

Scenario 1: False hypogonadism. A 45-year-old man on phenytoin for a seizure disorder has a total testosterone of 280 ng/dL. His provider diagnoses testosterone deficiency and starts TRT. But his SHBG is 72 nmol/L (phenytoin-elevated). Calculated free testosterone is actually 5.8 ng/dL, within the normal reference range. He never needed TRT.

Scenario 2: Missed deficiency. A 52-year-old woman on danazol for endometriosis has a total testosterone of 45 ng/dL, which looks reasonable for a woman. But her SHBG is 12 nmol/L (danazol-suppressed), and her free testosterone is elevated at 1.8 ng/dL, explaining her acne and hirsutism. Treating the danazol effect is the correct clinical move, not adding spironolactone.

The American Association of Clinical Endocrinology (AACE) 2024 guidelines on testosterone management in women recommend: "In women on medications known to alter SHBG, free testosterone should be measured using a reliable assay rather than relying on total testosterone alone" [18]. This recommendation mirrors what the Endocrine Society advises for men.

Practical Steps for Accurate Testing

When a patient takes any SHBG-altering medication, a structured approach prevents misinterpretation.

Order the right panel. Request SHBG, total testosterone, albumin, and either calculated free testosterone (Vermeulen equation) or free testosterone by equilibrium dialysis. Direct analog free testosterone immunoassays are unreliable at low concentrations and should be avoided [2].

Time the draw correctly. For men, draw blood between 7:00 and 10:00 AM when testosterone peaks. For women not on oral contraceptives, draw in the early follicular phase (days 3-7). If the patient recently started or stopped an SHBG-altering drug, wait at least 6-8 weeks for a new steady state before interpreting results [19].

Document the medication list. Flag every drug on the SHBG-altering list and note it on the lab order. This context is as important as the numbers themselves.

Consider switching routes. For women on oral estradiol who need accurate testosterone assessment, a temporary or permanent switch to transdermal estradiol eliminates the hepatic SHBG surge without changing systemic estrogen exposure [6].

Repeat when in doubt. SHBG has moderate intra-individual variability (coefficient of variation around 8-12%). A single abnormal value on a medication known to shift SHBG should prompt a confirmatory repeat before clinical decisions are made [19].

How to Raise or Lower SHBG When Clinically Indicated

SHBG is not typically a direct treatment target. But in specific situations, adjusting it changes clinical outcomes.

Raising SHBG. In women with PCOS and low SHBG driven by hyperinsulinemia, weight loss of 5-10% body weight raises SHBG by 20-30%. A randomized trial of 74 overweight women with PCOS demonstrated that a 7% weight loss over 6 months increased SHBG from 25.3 to 34.1 nmol/L (P<0.01) [20]. Adding a COC raises SHBG further and is often used to reduce free androgen levels. Reducing alcohol intake and managing hypothyroidism also contribute to SHBG normalization.

Lowering SHBG. In men with high SHBG causing low free testosterone despite normal total testosterone, low-dose boron supplementation (6-10 mg/day) has shown modest SHBG-lowering effects in small studies, though evidence remains preliminary [21]. Optimizing body composition (adding lean mass, reducing visceral fat) helps by improving insulin sensitivity. Some clinicians use more frequent, lower-dose testosterone injections (e.g., 50-80 mg subcutaneous twice weekly instead of 200 mg intramuscular every two weeks) to stabilize levels and attenuate SHBG suppression from peak-trough cycling.

The goal is never to force SHBG into a specific number. The goal is to ensure the free hormone fractions reflect actual tissue exposure.